Objective: A genomic region near the CDKN2A locus, encoding p16
Introduction
Genome-wide association studies (GWAS) identified a linkage disequilibrium between several single nucleotide polymorphisms (SNPs) in non-coding regions of the human chromosome 9p21 and the risk for type 2 diabetes [1] and atherosclerotic vascular disease [2] . The coding sequences closest to this locus include CDKN2A (coding for the cyclin-dependent kinase [CDK] inhibitors p16 INK4a and its alternative reading frame transcript variant p14 ARF ), CDKN2B (coding for the CDK inhibitor p15 INK4b ) [3] , and ANRIL, an antisense non-coding RNA [4] partially overlapping the high risk interval [5] . The gene products of the CDKN2A/B locus are known tumor suppressors which function as cell cycle inhibitors [3] . ANRIL is implicated in CDKN2A [6] and CDKN2B [7] silencing and ANRIL expression strongly correlates with the identified risk-associated SNPs [8] . In line, several of these SNPs correlate with p16
INK4a and p15
INK4b expression levels in peripheral blood cells [8] , suggesting a role for the gene products of the CDKN2A/B locus in the found genetic association. Interestingly, deletion of a region of mouse chromosome 4, orthologous to the human 9p21 risk interval, was shown to increase body weight, further linking this region with obesity and metabolic risk [9] . Atherosclerosis formation induced by a cholatecontaining diet was not affected. However, these mice were not crossed in an atherosclerosis-prone genetic background [9] , making data interpretation very difficult with respect to atherosclerosis. Using a series of subcongenic mouse strains, Kuo et al. recently linked this genomic region to decreased p16
INK4a and p19 ARF (the murine variant of p14 ARF ) gene expression in macrophages and monocytes and to atherosclerosis formation in the atherosclerosis-prone low density lipoprotein receptor-deficient (ldlr 2/2 ) background [10] . Additionally, p19 ARF -deficiency has been shown to be pro-atherogenic in an apolipoprotein E-deficient (apoe 2/2 ) background [11] . Although the latter study did not clearly identify the cell type involved, the study of Kuo et al. showed that bone marrow-specific reduced CDKN2A expression (including p16
INK4a and p19
ARF
) is required and sufficient to accelerate atherosclerosis formation in ldlr 2/2 mice [10] . However, the individual contribution of p16
INK4a remains unknown. Bone marrow cells give rise to immune cells, which play a crucial role during the initiation and propagation of type 2 diabetes and atherosclerosis. A key event in type 2 diabetes and atherosclerosis is the recruitment of inflammatory cells to, respectively, adipose tissue (AT) [12] and the neo-intima of large arteries [13] . p16
INK4a is expressed in macrophages of human atherosclerotic plaques, where it correlates with the expression of the macrophage marker CD68 and with tumor necrosis factor (TNF) [14] . Recently, we showed that p16
INK4a
-deficiency in murine bone marrow-derived macrophages inhibits inflammatory JAK2-STAT1 signaling, promoting the polarization into alternatively activated (M2) macrophages [15] , which have been shown to protect against the development of obesity-induced glucose intolerance and insulin resistance [16] . In addition, p16
INK4a plays a role in T-lymphocytes, an immune cell type involved in type 2 diabetes [17] and atherosclerosis [13] development, by inhibiting their activation-induced proliferation [18] and by inducing apoptosis [19] . Moreover, we have recently discovered that p16
INK4a expression levels play a role in determining the inflammatory phenotype of adipose tissue macrophages (ATM) [20] .
Given the role of immune cell p16
, given the association of the CDKN2A locus to cardiovascular disease and type 2 diabetes and given the effects of bone marrow CDKN2A-deficiency on atherosclerosis development, we investigated the contribution of bone marrow p16
-deficiency to the development of obesity, glucose intolerance and atherosclerosis in appropriate mouse models.
Materials and Methods

Mice and diets
Low density lipoprotein receptor-deficient (ldlr 2/2 ) acceptor mice were house-bred and C57BL/6J acceptor mice were purchased from Charles River. All protocols were conducted with the approval of the ethical review boards of the Pasteur Institute, Lille, France (CEEA 13/2010) and Maastricht University, Maastricht, The Netherlands (DEC 2007-117). p16
INK4a -deficient mice on the C57BL/6J background (.97%) were kindly provided by P. Krimpenfort.
For metabolic experiments, chimeric male C57/BL/6J mice were given a high fat diet (HFD) containing 20% lard and 35% sucrose (Ssniff, Germany). For atherosclerosis experiments, chimeric female ldlr 2/2 mice were given western diet containing 21% milk butter and 0.2% cholesterol (Safe, France).
After the dietary period, blood samples were collected be retroorbital puncture and animals were sacrificed by cervical dislocation and organs were snap frozen for further analysis.
Biochemical analysis
Plasma levels of total cholesterol (TC), triglycerides (TG) and high density lipoprotein cholesterol (HDL-C) were measured using commercially available kits (BioMérieux). Non-HDL-cholesterol (N-HDL-C) was calculated by subtraction of HDL-C from TC. Alanine aminotransferase (ALAT) (Biolabo), aspartate aminotransferase (ASAT) (Biolabo), insulin (Mercodia) and free fatty acid (Diasys) levels were determined according to the manufacturer's instructions.
Bone marrow transplantation (BMT)
8 week-old male C57BL/6J or female ldlr 2/2 mice were lethally irradiated (8 Gy) and tail vein injected the next day with 10 7 bone marrow cells isolated from 8 week-old p16 2/2 or p16
littermate donor mice. Mice received autoclaved acidified water (pH = 2) supplemented with neomycin 100 mg/L (Cat.N1142, Sigma-Aldrich) and polymyxin B sulphate 60000 U/L (Cat.21850029, Invitrogen) 1 week before and 4 weeks after transplantation. Mice were studied 6 weeks post-transplantation allowing complete repopulation by the donor bone marrow. To ensure that donor bone marrow efficiently replaced the resident blood cell population, DNA was extracted from whole blood with an Illustra blood kit (GE Healthcare). PCR was performed with the forward 59-GCA-GTG-TTG-CAG-TTT-GAA-CCC-39 and reverse 59-TGT-GGC-AAC-TGA-TTC-AGT-TTG-39 primers, yielding products of different lengths depending on the genotype, separated on a 1.5% agarose gel and quantified with the Gel Doc XR system (Bio-Rad). Over 95% of host blood cells were from donor origin. Flow cytometric analysis of blood cell populations was performed as described [21] .
Isolation of the stromal vascular fraction from white adipose tissue (WAT)
AT was cut into small pieces, washed with PBS and digested in Krebs buffer (pH = 7.4) containing collagenase (1.5 mg/ml, Roche Diagnostic) at 37uC during 1 h, filtered through a 200 mm filter (Spectra Mesh nylon filters; Biovalley) and centrifuged at 1500 rpm for 15 min to separate floating adipocytes. After two washes of the adipocyte fraction with PBS, adipocytes were collected and kept at 280uC for DNA and RNA extraction. The Stromal Vascular cell Fraction (SVF) was pelleted and red blood cells were lysed with erythrocyte lysis buffer (NH 4 Cl, 131 mM; NH 4 CO3, 9 mM; EDTA, 1 mM; pH 7.4) for 5 min; the remaining cells were filtered through filter meshes with pore size of 70 mm (Spectra Mesh nylon filters; Biovalley). SVF was subjected to Magnetic-Activated Cell Sorting (MACS) in order to isolate ATM CD11b + cells using CD11b-labelled magnetic beads (Miltenyi Biotec) according to the manufacturer's instructions. The CD11b 2 fraction was cultured in Preadipocyte Basal Medium (PBM, Promocell) for 24 h to eliminate cell types other than preadipocytes. Only adherent cells were used for RNA and DNA extraction. RNA extraction was performed using RNeasy kits (Qiagen) and DNA extraction with Nucleospin Tissue columns (Marchery-Nagel) according to the manufacturer's instructions. PCR was performed as described for blood chimerism.
RNA quantification by real-time PCR
Tissue RNA was isolated using the guanidinium thiocyanate (GSCN)/phenol/chloroform extraction method and 1 mg mRNA was reverse transcribed using the SuperScript First-strand Synthesis System for Reverse transcription (Life Technologies, Gaithersburg, MD, USA). Reverse transcribed cDNAs were quantified by SYBR green-based real-time PCR using specific oligonucleotides on a Mx3000 apparatus (Stratagene, La Jolla, CA). mRNA levels were normalized to cyclophilin expression as internal control. 
Glucose Tolerance Tests (GTT)
Blood samples were collected from the tail vein at 0, 5, 15, 30, 60, 90 or 120 min after a bolus glucose (1 g/kg) injection (after fast 6 hours of fasting) and glycemia was measured using a Glucometer (Accu-Check activeH, Roche Applied Science). To avoid timedependent effects, GTT were performed at 2 different time points, i.e. after 16 and 20 weeks of high fat feeding. To circumvent influences of glucose injection on hepatic gene expression, animals 
Macrophage cholesterol assays
Bone marrow-derived macrophages (BMDM) were obtained from femoral and tibial bone marrow suspensions plated at 10610 6 cells in 10 cm plates and differentiated in bone marrow medium (RPMI 1640 containing Hepes 25 mM supplemented with 10% low endotoxin fetal bovine serum, 15% L929-conditioned medium, 2 mM L-glutamine, 1 mM gentamycine). Cholesterol esterification was assessed by measuring the incorporation of [14C]-oleate into cholesteryl esters after incubation with acetylated (Ac) LDL (50 mg/mL) for 24 and 48 hours. After the cholesterol-loading period, cholesteryl ester formation was measured as described [22] . Cholesterol efflux to HDL was measured after macrophage cholesterol-loading with [3H]cholesterolAcLDL (50 mg/mL) for 48 h as described [22] .
Atherosclerotic Lesion analysis
Mice were euthanized by cervical dislocation and the heart of each animal was rinsed with PBS and fixed with 4% phosphatebuffered paraformaldehyde (pH = 7.4). Serial 10-mm-thick sections were cut between the valves and the aortic arch and lipid deposition was quantitatively analyzed by Oil red-O staining. Toluidine staining and Sirius red staining were performed and plaque morphology and stability were scored by a blinded animal pathologist as described [21] . Immunohistochemical analysis of TNF and MCP1 was performed using specific antibodies (Santa Cruz Biotechnology), followed by detection with biotinylated secondary antibodies and streptavidin-horseradish peroxidase. Immunostainings were visualized using the DAB substratechromogen system (DAKO Corporation, Carpinteria, Calif). Images were captured using a JVC 3-charge-coupled device video camera. Sections were analyzed using the computer-assisted Quips Image analysis system (Leica Mikroskopic und System GmbH, Wetzlar, Germany).
Statistical analysis
Groups were compared using 2-tailed non-paired t-tests or 2-way ANOVA using GraphPad Prism software. In vitro data are expressed as means 6 SD and in vivo data are expressed as means 6 SEM.
Results
Bone marrow p16
INK4a -deficiency does not affect high fat diet-induced obesity or glucose intolerance
Since we previously observed that p16
INK4
-deficiency modulates the inflammatory phenotype of murine macrophages [15] and since p16
INK4a knock-down directs human macrophages toward an ATM-like phenotype [20] , we analyzed the contribution of the bone marrow p16
INK4a
-deficiency to diet-induced adipose tissue development and glucose intolerance in mice. C57BL/6 mice were transplanted with either wild-type (p16 +/+ BMT) or p16
INK4a -deficient (p16 2/2 BMT) bone marrow. After 6 weeks of recovery, over 95% of blood cells were from donor origin (data not shown) and blood immune cell composition was similar between the genotypes (data not shown). Importantly, after 16 weeks of HFD feeding, the presence of donor cells in the macrophage (CD11b + ) fraction of adipose tissue (AT) was over 85% while neither mature adipocytes, nor preadipocytes were from donor origin (Fig. 1A) . The animals were fed a HFD during 22 weeks and body weight and blood parameters were monitored. Food intake was equal during the dietary period (data not shown). No difference was observed in body weight gain between p16 +/+ BMT and p16 2/2 BMT mice either on normal chow diet or on a HFD (Fig. 1B) . At the end of the dietary period, neither body weight (Fig. 1C) , inguinal AT (iAT) (Fig. 1D) , epidydimal AT (eAT) (Fig. 1E ) nor liver weight (Fig. 1F ) were different between the genotypes. Plasma levels of glucose, insulin, free fatty acids (FFA), liver enzymes (ALT/AST) and lipids did not differ between p16 +/+ BMT and p16 2/2 BMT mice after 22 weeks on chow or on a HFD (Table 1) .
No difference in glucose tolerance was observed between p16 +/+ BMT and p16 2/2 BMT mice on chow or after either 16 weeks or 20 weeks of HFD ( Fig. 2A-D) , time points when at least 85% of ATMs were from donor origin (Fig. 1A) . Since p16
INK4a alters macrophage polarization status [15] and since obesity is associated with a shift toward classically activated macrophages in AT [23] and in the liver [24] , macrophage polarization markers were measured in these organs. The gene expression profile of AT from p16 2/2 BMT mice revealed no difference in the HFD-induced expression (compared to low fat chow-fed animals as baseline) of either alternatively or classically activated macrophage markers compared to p16 +/+ BMT mice (Fig. 3A) . Interestingly, hepatic HFD-induced expression (compared to low fat chow-fed animals as baseline) of the alternative marker IL10 was higher and the induction of Chi3l3 tended to be higher (p = 0.065) in p16 2/2 BMT mice. Moreover, Mgl2 was induced in p16 2/2 BMT mice but not in p16 +/+ BMT mice (Fig. 3B) . Contrary, the induction of the classical marker NOS2 was completely ablated compared to p16 +/+ BMT mice (Fig. 3B) . Collectively, these data show that bone marrow p16
deficiency does not modulate HFD-induced obesity or glucose metabolism.
Bone marrow p16
INK4a -deficiency does not influence atherosclerosis size or lesion composition in hyperlipidemic ldlr 2/2 mice
Since bone marrow CDKN2A-deficiency in ldlr 2/2 mice increases atherosclerosis development [10] , we investigated the specific contribution of bone marrow p16
INK4a -deficiency to atherosclerosis development. Atherosclerosis-prone ldlr 2/2 mice were transplanted with either wild-type (p16 +/+ BMT ldlr 2/2 ) or p16
INK4a -deficient (p16 2/2 BMT ldlr 2/2 ) bone marrow [25] . The animals were fed a western diet during 9 weeks and physiological parameters and atherosclerosis development were monitored, a time point comparable to the one where the effects of bone marrow CDKN2A-deficiency were observed [10] .
Blood cell replacement was higher than 95% and no differences were observed in blood monocyte, neutrophil, B-lymphocyte or Tlymphocyte composition (data not shown). No differences were observed in plasma TC, HDL-C, non-HDL-C or TG between p16 +/+ BMT ldlr 2/2 and p16 2/2 BMT ldlr 2/2 mice (Table 1) . Intracellular cholesterol metabolism in macrophages is a determining factor of plaque initiation and formation [26] . Therefore, since IFNc influences foam cell formation by diminishing cholesterol efflux [27] and since p16
INK4a -deficiency alters IFNc-induced signaling [15] , uptake and efflux of cholesterol in wild type and in p16
INK4a -deficient macrophages were compared. As shown in Fig. 4 , cholesterol uptake as well as efflux to HDL in p16
INK4a -deficient BMDM was equal compared to their wild type counterparts.
After 9 weeks of western diet, no differences were observed in mean plaque size (Fig. 5A ) or in plaque size distribution (Fig. 5B) . Moreover, neither plaque Sirius Red-positive collagen content (Fig. 5C ), nor the inflammatory phenotype, illustrated by immunohistochemical staining of plaque MCP1 (Fig. 5D) and TNF (Fig. 5E) , were affected. Additionally, blind scoring of toluidine-stained sections by an animal pathologist showed no changes in plaque necrosis, foam cell content, monocyte adhesion, neutrophil content or adventitial influx (data not shown).
Collectively, these data show that bone marrow p16
INK4a -deficiency does not alter atherosclerosis development or plaque phenotype in ldlr 2/2 mice.
Discussion
Genetic susceptibility contributes significantly to cardiovascular disease [28, 29] and type 2 diabetes [30] risk. Therefore, the identification of genes and mechanisms behind newly found genetic associations, such as for p16 INK4a , will provide new insights and therapeutic possibilities for targeting atherosclerosis and type 2 diabetes. The locus coding for p16
INK4a has been linked to the risk for type 2 diabetes [1] and atherosclerotic vascular disease [2] and bone marrow-specific heterozygous deletion of CDKN2A (including p16
INK4a and p19 ARF , the murine variant of p14 ARF ) is required and sufficient to accelerate atherosclerosis formation [10] . Therefore, we investigated the specific role of bone marrow p16
INK4a on obesity, glucose tolerance and atherosclerosis glucose intolerance or atherosclerosis. These observations shed light on the found linkage disequilibrium found in GWAS between these conditions and the CDKN2A/B region. The effects of p16
INK4a -deficiency on inflammatory phenotype thus appear insufficient to affect atherosclerosis or the development of obesity and glucose intolerance suggesting the involvement of other cell types, other gene products or combinations thereof in the CDKN2A/B genomic region. 
